Xu L - Search Results

1

High expression of PIWIL2 promotes tumor cell proliferation, migration and predicts a poor prognosis in glioma.

Li J, Xu L, Bao Z, Xu P, Chang H, Wu J, Bei Y, Xia L, Wu P, Cui G. Li J, et al. Among authors: xu l, xu p. Oncol Rep. 2017 Jul;38(1):183-192. doi: 10.3892/or.2017.5647. Epub 2017 May 17. Oncol Rep. 2017. PMID: 28534979

2

Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.

Gao HJ, Zhao MC, Zhang YJ, Zhou DS, Xu L, Li GB, Chen MS, Liu J. Gao HJ, et al. Among authors: xu l. J Cancer Res Clin Oncol. 2015 Jul;141(7):1151-62. doi: 10.1007/s00432-014-1888-8. Epub 2014 Dec 2. J Cancer Res Clin Oncol. 2015. PMID: 25446815

3

LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.

Maki Y, Fujimoto J, Lang W, Xu L, Behrens C, Wistuba II, Kadara H. Maki Y, et al. Among authors: xu l. Sci Rep. 2015 Sep 7;5:13846. doi: 10.1038/srep13846. Sci Rep. 2015. PMID: 26343532 Free PMC article.

4

IGFBP6 Regulates Cell Apoptosis and Migration in Glioma.

Bei Y, Huang Q, Shen J, Shi J, Shen C, Xu P, Chang H, Xia X, Xu L, Ji B, Chen J. Bei Y, et al. Among authors: xu l, xu p. Cell Mol Neurobiol. 2017 Jul;37(5):889-898. doi: 10.1007/s10571-016-0426-4. Epub 2016 Sep 21. Cell Mol Neurobiol. 2017. PMID: 27650075

5

Angiogenin elevates the invasive potential of squamous cell lung carcinoma cells through epithelial‑mesenchymal transition.

Xu L, Yan Y, Xue X, Li CG, Xu ZY, Chen HZ. Xu L, et al. Among authors: xu zy. Oncol Rep. 2016 Nov;36(5):2836-2842. doi: 10.3892/or.2016.5107. Epub 2016 Sep 19. Oncol Rep. 2016. PMID: 27667357

6

Silencing of OTUB1 inhibits migration of human glioma cells in vitro.

Xu L, Li J, Bao Z, Xu P, Chang H, Wu J, Bei Y, Xia L, Wu P, Yan K, Lu B, Cui G. Xu L, et al. Among authors: xu p. Neuropathology. 2017 Jun;37(3):217-226. doi: 10.1111/neup.12366. Epub 2017 Jan 31. Neuropathology. 2017. PMID: 28139865

7

DTX3L is upregulated in glioma and is associated with glioma progression.

Xu P, Tao X, Zhao C, Huang Q, Chang H, Ban N, Bei Y, Xia X, Shen C, Wang K, Xu L, Wu P, Ren J, Wang D. Xu P, et al. Among authors: xu l. Int J Mol Med. 2017 Aug;40(2):491-498. doi: 10.3892/ijmm.2017.3023. Epub 2017 Jun 13. Int J Mol Med. 2017. PMID: 28627634

8

High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer.

Luo X, Hou N, Chen X, Xu Z, Xu J, Wang L, Yang S, Liu S, Xu L, Chen Y, Xiong L, Wang J, Fan W, Xu J. Luo X, et al. Among authors: xu l, xu z, xu j. Cancer Biomark. 2018 Feb 6;21(2):461-469. doi: 10.3233/CBM-170711. Cancer Biomark. 2018. PMID: 29171988

9

Regulation of HSF1 protein stabilization: An updated review.

Huang C, Wu J, Xu L, Wang J, Chen Z, Yang R. Huang C, et al. Among authors: xu l. Eur J Pharmacol. 2018 Mar 5;822:69-77. doi: 10.1016/j.ejphar.2018.01.005. Epub 2018 Jan 16. Eur J Pharmacol. 2018. PMID: 29341886 Review.

10

FLOT1 promotes tumor development, induces epithelial-mesenchymal transition, and modulates the cell cycle by regulating the Erk/Akt signaling pathway in lung adenocarcinoma.

Zhang L, Mao Y, Mao Q, Fan W, Xu L, Chen Y, Xu L, Wang J. Zhang L, et al. Among authors: xu l. Thorac Cancer. 2019 Apr;10(4):909-917. doi: 10.1111/1759-7714.13027. Epub 2019 Mar 5. Thorac Cancer. 2019. PMID: 30838797 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,945 results

Search Page

Filters